Form 8-K - Current report:
SEC Accession No. 0001193125-25-062629
Filing Date
2025-03-25
Accepted
2025-03-25 16:46:55
Documents
19
Period of Report
2025-03-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d943630d8k.htm   iXBRL 8-K 30941
2 EX-1.1 d943630dex11.htm EX-1.1 204567
3 EX-5.1 d943630dex51.htm EX-5.1 13104
4 EX-99.1 d943630dex991.htm EX-99.1 55363
8 GRAPHIC g943630g0324214625452.jpg GRAPHIC 1649
9 GRAPHIC g943630g0324214625656.jpg GRAPHIC 1639
10 GRAPHIC g943630snap1.jpg GRAPHIC 10116
  Complete submission text file 0001193125-25-062629.txt   524846

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA clym-20250325.xsd EX-101.SCH 2842
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE clym-20250325_lab.xml EX-101.LAB 18738
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clym-20250325_pre.xml EX-101.PRE 11702
21 EXTRACTED XBRL INSTANCE DOCUMENT d943630d8k_htm.xml XML 3766
Mailing Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481
Business Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481 1-866-857-2596
Climb Bio, Inc. (Filer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40708 | Film No.: 25768967
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)